Literature DB >> 6213689

Ligand binding and platelet uptake studies of loxapine, amoxapine and their 8-hydroxylated derivatives.

A Fulton, T Norman, G D Burrows.   

Abstract

Loxapine, amoxapine and their 8-hydroxylated derivatives were studied by means of [3H]imipramine binding to rat cortical membranes, [3H]spiperone binding to rat striatal membranes, and the inhibition of serotonin uptake by human platelets. As inhibitors of [3H]imipramine binding: amoxapine greater than hydroxyamoxapine greater than loxapine = hydroxyloxapine; as inhibitors of platelet serotonin uptake: hydroxyamoxapine greater than amoxapine greater than hydroxyloxapine greater than loxapine; and as inhibitors of [3H]spiperone binding: loxapine greater than amoxapine greater than hydroxyamoxapine greater than hydroxyloxapine. The antipsychotic properties of loxapine and amoxapine were supported by the binding results, which also indicated the probable antipsychotic activities of the metabolites. All 4 compounds may possess dual action of antidepressant effect as well as antipsychotic effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213689     DOI: 10.1016/0165-0327(82)90041-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  Amoxapine: a review of its pharmacology and efficacy in depressed states.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

2.  Intracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release Mechanism.

Authors:  Terry Petrou; Hervør L Olsen; Christopher Thrasivoulou; John R Masters; Jonathan F Ashmore; Aamir Ahmed
Journal:  J Pharmacol Exp Ther       Date:  2016-12-15       Impact factor: 4.030

3.  Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo.

Authors:  Huanzhen Ni; Marine Z C Hatit; Kun Zhao; David Loughrey; Melissa P Lokugamage; Hannah E Peck; Ada Del Cid; Abinaya Muralidharan; YongTae Kim; Philip J Santangelo; James E Dahlman
Journal:  Nat Commun       Date:  2022-08-15       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.